secondary malignancies of T-cell originEuropean Medicines AgencyCAR T-cell medicines
…Medicines Agency. CAR T-cell medicines: PRAC identifies risk of secondary malignancies of T-cell origin [online], 2024. Available: https://www.ema.europa.eu/en/news/me…